ImmunoCellular Therapeutics to Report Financial Results for the First Quarter 2013 May 9, 2013

ImmunoCellular Therapeutics to Report Financial Results for the First Quarter 2013 May 9, 2013

LOS ANGELES--(BUSINESS WIRE)-- ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (NYSE MKT: IMUC) today announced that it plans to report first quarter 2013 financial results on Thursday, May 9, 2013. ImmunoCellular will host a conference call and webcast to discuss financial results and provide a business update at 5:00 p.m. ET that day. The call will be hosted by Andrew Gengos, President and CEO.

 

LIVE CALL:

      877-853-5636 (toll-free)
Conference code: 49554635
 

REPLAY:

855-859-2056 (toll-free)
404-537-3406
Conference code: 49554635
(Replay available from Thursday, May 9, 2013 at 8:00 p.m. until Thursday, May 16, 2013 at 11:59 p.m.)
 

The conference call will contain forward-looking statements. Interested parties who wish to listen to the webcast should visit the Investor Relations section of ImmunoCellular's website at www.imuc.com. The information provided on the teleconference is accurate only at the time of the conference call, and ImmunoCellular will take no responsibility for providing updated information except as required by law.

About ImmunoCellular Therapeutics, Ltd.

ImmunoCellular Therapeutics, Ltd. is a Los Angeles-based clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers. ImmunoCellular is conducting a Phase II trial of its lead product candidate, ICT-107, a dendritic cell-based vaccine targeting multiple tumor-associated antigens for glioblastoma. ImmunoCellular’s pipeline also includes ICT-121, a dendritic cell vaccine targeting CD133, and ICT-140, a dendritic cell vaccine targeting ovarian cancer antigens and cancer stem cells. To learn more about ImmunoCellular, please visit www.imuc.com.



ImmunoCellular Therapeutics, Ltd.
Investor Relations
Jane Green
415-348-0010 direct
415-652-4819 mobile
jane@jmgcomm.com

KEYWORDS:   United States  North America  California

INDUSTRY KEYWORDS:

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2399423, ~/Articles/ArticleHandler.aspx, 11/26/2014 1:33:04 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...